Brief: Vtv Therapeutics Announces $51 Million Private Placement
28/02/2024 13:26
Feb 28 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS ANNOUNCES $51 MILLION PRIVATE PLACEMENT
FROM
HEALTHCARE-FOCUSED INSTITUTIONAL INVESTORS AND THE JDRF T1D FUND
* VTV THERAPEUTICS INC - EXPECTS TO USE PROCEEDS FROM PIPE
TO FUND
FIRST PHASE 3 STUDY OF ITS LEAD PRODUCT CANDIDATE, CADISEGLIATIN
* VTV THERAPEUTICS INC - IN CONJUNCTION WITH PIPE, VTV HAS
REDUCED
SIZE OF ITS BOARD OF DIRECTORS FROM NINE TO SEVEN MEMBERS
Source text for Eikon: ID:nGNX2dX4Z2
Further company coverage: VTVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)